Medicine
Abiraterone 250 mg tablet
Abiraterone 250 mg tablet is a generic prescription medicine for oral use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted in the range from…
Key facts
- Active ingredient (INN)
- Abiraterone
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 120 tablets, 3 blister pack, 500 tablets and 22 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaNovadoz PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaNorthStar RxAmerican Health PackagingAmneal PharmaceuticalsAmneal Pharmaceuticals NYApotexAvKAREAvPAK
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted in the range from 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02BX03 Abiraterone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 November 2018
- Identifiers
- RxCUI 1100075, 1918042DailyMed set ID 6f5b628b-69da-4a04-a4d5-623b18d1fd5d, 2ac063f0-4177-c90f-27c3-e70e29689255, 7f82d549-6654-1efd-e053-2991aa0aa28d +19NDC 82009-139, 60505-4327, 42291-024 +20Application ANDA210686, ANDA208453, ANDA208327 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 120 tablet in 1 bottle | 43598-358-04 | Dr. Reddy's LaboratoriesIndia | 19 May 2020 |
| 3 blister pack in 1 carton / 10 tablet in 1 blister pack | 43598-358-31 | Dr. Reddy's LaboratoriesIndia | 20 December 2021 |
| 120 tablet in 1 bottle | 75907-224-04 | Dr. Reddy's LaboratoriesIndia | 17 March 2025 |
| 120 tablet in 1 bottle | 72205-030-92 | Novadoz PharmaceuticalsIndia | 10 July 2019 |
| 500 tablet, film coated in 1 bottle | 72205-284-05 | Novadoz PharmaceuticalsIndia | 24 May 2024 |
| 120 tablet, film coated in 1 bottle | 72205-284-92 | Novadoz PharmaceuticalsIndia | 24 May 2024 |
| 120 tablet in 1 bottle | 68462-135-08 | Glenmark PharmaceuticalsIndia | 16 October 2019 |
| 120 tablet in 1 bottle | 60219-1165-7 | Amneal Pharmaceuticals | 28 April 2023 |
| 120 tablet in 1 bottle | 69238-1165-7 | Amneal Pharmaceuticals NY | 7 January 2019 |
| 120 tablet in 1 bottle | 60505-4327-1 | Apotex | 23 November 2018 |
| 120 tablet in 1 bottle, plastic | 82249-010-12 | CivicaScript | 27 June 2022 |
| 120 tablet in 1 bottle | 71921-178-20 | Florida Pharmaceutical Products | 15 August 2022 |
| 120 tablet in 1 bottle | 0143-9597-21 | Hikma Pharmaceuticals | 23 November 2018 |
| 120 tablet in 1 bottle, plastic | 0378-6920-78 | Mylan Pharmaceuticals | 21 November 2018 |
| 120 tablet, film coated in 1 bottle, plastic | 82293-001-10 | Novugen Pharma | 5 January 2022 |
| 120 tablet in 1 bottle | 64980-418-12 | Rising Pharma Holdings | 25 February 2019 |
| 120 tablet in 1 bottle | 16714-963-01 | NorthStar Rx | 19 May 2020 |
| 120 tablet in 1 bottle | 72603-110-01 | Northstar RX | 7 March 2022 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 60687-790-21 | American Health Packaging | 31 July 2024 |
| 120 tablet in 1 bottle | 42291-024-12 | AvKARE | 14 January 2019 |
| 20 blister pack in 1 box / 1 tablet in 1 blister pack | 50268-032-12 | AvPAK | 4 May 2026 |
| 120 tablet in 1 bottle | 68001-489-07 | BluePoint Laboratories | 26 February 2021 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 0904-6948-04 | Major Pharmaceuticals | 23 November 2018 |
| 120 tablet in 1 bottle, plastic | 72789-213-98 | PD-Rx Pharmaceuticals | 11 October 2021 |
| 120 tablet in 1 bottle | 82009-139-12 | Quallent Pharmaceuticals Health | 15 June 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Abiraterone 250 mg tablet.
Other strengths and forms of Abiraterone
Clinical summary
Abiraterone is a cytochrome P450 17A1 inhibitor. It is available as tablets for oral use. MedsAcross supplies Abiraterone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AbirateroneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zytiga prescribing information (Janssen Biotech) · U.S. National Library of Medicine, DailyMed
- Zytiga: European public assessment report (EPAR) · European Medicines Agency
- Abiraterone Accord: European public assessment report (EPAR) · European Medicines Agency
Need Abiraterone 250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.